Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion type Assertion NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_head.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion description "[In patient biofluid specimens, mir-143(2) members were 2.9-fold higher in urine cells from ADPKD compared to other CKD patients, while expression levels of mir-133b(2) (4.9-fold) and mir-1(4) (4.4-fold) were lower in ADPKD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_provenance.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion evidence source_evidence_literature NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_provenance.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion SIO_000772 24489795 NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_provenance.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion wasDerivedFrom befree-20150227 NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_provenance.
- NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_assertion wasGeneratedBy ECO_0000203 NP1001246.RAZt7-nONxDvtksWA6NFmXsVMnO5TGN4MdUHZf9rE6cPs130_provenance.